Citigroup Inc Uni Qure N.V. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Citigroup Inc holds 4,295 shares of QURE stock, worth $72,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,295

Previous 49,485 91.32%

Holding current value

$72,929

Previous $221,000 90.5%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.78 - $10.12 $170,818 - $457,322	-45,190 Reduced 91.32%	4,295 $21,000
Q2 2024 Aug 12, 2024	BUY	$4.39 - $5.43 $41,687 - $51,563	9,496 Added 23.75%	49,485 $221,000
Q1 2024 May 10, 2024	SELL	$4.82 - $6.93 $3.39 Million - $4.88 Million	-703,921 Reduced 94.62%	39,989 $207,000
Q4 2023 Feb 09, 2024	SELL	$5.63 - $8.27 $127,299 - $186,992	-22,611 Reduced 2.95%	743,910 $5.04 Million
Q3 2023 Nov 09, 2023	BUY	$6.71 - $11.83 $4.47 Million - $7.89 Million	666,696 Added 667.86%	766,521 $5.14 Million
Q2 2023 Aug 10, 2023	SELL	$11.12 - $22.2 $2.29 Million - $4.57 Million	-206,035 Reduced 67.36%	99,825 $1.14 Million
Q1 2023 May 11, 2023	BUY	$18.7 - $23.07 $1.82 Million - $2.25 Million	97,559 Added 46.84%	305,860 $6.16 Million
Q4 2022 Feb 09, 2023	SELL	$18.12 - $27.32 $1.88 Million - $2.83 Million	-103,593 Reduced 33.21%	208,301 $4.72 Million
Q3 2022 Nov 10, 2022	BUY	$16.98 - $25.54 $1.91 Million - $2.87 Million	112,355 Added 56.31%	311,894 $5.85 Million
Q2 2022 Aug 10, 2022	BUY	$13.15 - $20.45 $588,160 - $914,667	44,727 Added 28.89%	199,539 $3.72 Million
Q1 2022 May 12, 2022	SELL	$14.54 - $21.5 $424,059 - $627,047	-29,165 Reduced 15.85%	154,812 $2.8 Million
Q4 2021 Feb 10, 2022	BUY	$20.24 - $36.01 $75,434 - $134,209	3,727 Added 2.07%	183,977 $3.82 Million
Q3 2021 Nov 10, 2021	BUY	$26.01 - $38.22 $4.69 Million - $6.89 Million	180,250 New	180,250 $5.77 Million

Others Institutions Holding QURE

# of Institutions

154

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $793M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account